Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Exchange Rate Effect (2019 - 2025)

Tandem Diabetes Care's Exchange Rate Effect history spans 7 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 41.37% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.6 million, up 28.34%, while the annual FY2025 figure was $1.6 million, 28.34% up from the prior year.
  • Exchange Rate Effect reached $1.3 million in Q4 2025 per TNDM's latest filing, up from $605000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $2.2 million in Q4 2024 to a low of -$1.9 million in Q1 2025.
  • Average Exchange Rate Effect over 5 years is $181800.0, with a median of $22000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: tumbled 3200.0% in 2022, then skyrocketed 14600.0% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at $103000.0 in 2021, then skyrocketed by 903.88% to $1.0 million in 2022, then tumbled by 57.45% to $440000.0 in 2023, then surged by 392.27% to $2.2 million in 2024, then tumbled by 41.37% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Exchange Rate Effect are $1.3 million (Q4 2025), $605000.0 (Q3 2025), and $1.6 million (Q2 2025).